Grufity logo
Grufity logo

Latest Birchview Capital, LP Stock Portfolio

$213Million | No. of Holdings #72

Birchview Capital, LP Performance

2026 Q2+26.57%
YTD+31.16%
2025+10.92%

About Birchview Capital, LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Birchview Capital, LP reported an equity portfolio of $213.8 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Birchview Capital, LP are KLAC, BMY, LRCX. The fund has invested 25.2% of it's portfolio in KLA CORPORATION and 8% of portfolio in BRISTOL-MYERS SQUIBB CO. <br><br> The fund managers got completely rid off NOVOCURE LTD (NVCR), ENGENE HOLDINGS INC and ULTRAGENYX PHARMACEUTICAL INC (RARE) stocks. They significantly reduced their stock positions in OCULAR THERAPEUTIX INC (OCUL), COMPASS PATHWAYS LTD (CMPS) and LIPOCINE INC (LPCN). Birchview Capital, LP opened new stock positions in ABIVAX SA, VIR BIOTECHNOLOGY INC (VIR) and NOVO NORDISK A/S (NVO). The fund showed a lot of confidence in some stocks as they added substantially to HALOZYME THERAPEUTICS INC (HALO), NEKTAR THERAPEUTICS (NKTR) and GRACE THERAPEUTICS INC.
Birchview Capital, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$213Million
  as of Aug 14, 2026

Birchview Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Birchview Capital, LP made a return of 26.57% in the last quarter. In trailing 12 months, it's portfolio return was 69.53%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
abivax sa2,265,420
vir biotechnology inc2,241,800
bioage labs inc1,691,190
novo nordisk a/s1,150,560
adagene inc1,008,000
definium therapeutics inc940,800
silence therapeutics plc781,974
4d molecular therapeutics inc645,117
New stocks bought by Birchview Capital, LP

Additions

Ticker% Inc.
halozyme therapeutics inc229
nektar therapeutics161
grace therapeutics inc140
biogen inc80.00
zenas biopharma inc33.72
vera therapeutics inc31.27
corcept therapeutics inc21.19
compass therapeutics inc14.27
Additions to existing portfolio by Birchview Capital, LP

Reductions

Ticker% Reduced
ocular therapeutix inc-93.55
compass pathways ltd-92.00
lipocine inc-85.05
structure therapeutics inc-76.00
phathom pharmaceuticals inc-71.79
uniqure nv-49.65
karyopharm therapeutics inc-48.84
bicycle therapeutics plc-32.35
Birchview Capital, LP reduced stake in above stock

Sold off

Ticker$ Sold
engene holdings inc-1,702,500
novocure ltd-2,205,400
verastem inc-795,000
rocket pharmaceuticals inc-454,750
outset medical inc-379,707
regenxbio inc-555,343
ultragenyx pharmaceutical inc-1,298,900
kalvista pharmaceuticals inc-1,147,410
Birchview Capital, LP got rid off the above stocks

Sector Distribution

Birchview Capital, LP has about 56.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Technology
  • Others
  • Energy
Sector%
Healthcare56.9
Technology32.3
Others6.4
Energy3.5

Market Cap. Distribution

Birchview Capital, LP has about 49.5% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MEGA-CAP
  • SMALL-CAP
  • MID-CAP
  • LARGE-CAP
  • UNALLOCATED
  • MICRO-CAP
Category%
MEGA-CAP32.3
SMALL-CAP21.1
MID-CAP18
LARGE-CAP17.2
UNALLOCATED6.4
MICRO-CAP5

Stocks belong to which Index?

About 73% of the stocks held by Birchview Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

  • S&P 500
  • RUSSELL 2000
  • Others
Index%
S&P 50042.6
RUSSELL 200030.4
Others27
Top 5 Winners (%)%
QURE
uniqure nv
136.6 %
LRCX
lam research corporation
101.4 %
KLAC
kla corporation
99.5 %
CADL
candel therapeutics inc
99.0 %
CORT
corcept therapeutics inc
95.9 %
Top 5 Winners ($)$
KLAC
kla corporation
29.1 M
LRCX
lam research corporation
7.8 M
CORT
corcept therapeutics inc
2.4 M
BDSX
biodesix inc
2.3 M
QURE
uniqure nv
2.2 M
Top 5 Losers (%)%
CMPX
compass therapeutics inc
-57.0 %
GOSS
gossamer bio inc
-49.9 %
grace therapeutics inc
-42.4 %
LPCN
lipocine inc
-39.1 %
QNRX
quoin pharmaceuticals ltd
-26.7 %
Top 5 Losers ($)$
CMPX
compass therapeutics inc
-4.9 M
BMY
bristol-myers squibb co
-0.9 M
OVV
ovintiv inc
-0.7 M
OLMA
olema pharmaceuticals inc
-0.5 M
EQT
eqt corporation
-0.4 M

Birchview Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Birchview Capital, LP

Birchview Capital, LP has 72 stocks in it's portfolio. About 59.9% of the portfolio is in top 10 stocks. CMPX proved to be the most loss making stock for the portfolio. KLAC was the most profitable stock for Birchview Capital, LP last quarter.

$213.83MTotal Value
87.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Birchview Capital, LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ADAG
Adagene Inc

Adagene Inc

ADAG
Birchview Capital, LP's holding in Adagene Inc over time
0.47%240,000
$1.01M
0.47%
new position
CMPS
Compass Pathways Ltd

Compass Pathways Ltd

CMPS
Birchview Capital, LP's holding in Compass Pathways Ltd over time
0.2%30,000
$424.5K
0.2%
decreased 92 percentreduced